SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-015743
Filing Date
2022-04-25
Accepted
2022-04-25 16:30:26
Documents
4
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 DEF14A ny20002713x1_def14a.htm DEF 14A 1510782
2 logo_biocryst2a.jpg GRAPHIC 30535
3 ny20002713x1_pc01.jpg GRAPHIC 708872
4 ny20002713x1_pc02.jpg GRAPHIC 453616
  Complete submission text file 0001140361-22-015743.txt   3154101
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 22850051
SIC: 2836 Biological Products, (No Diagnostic Substances)